Sequence Ventures

Sequence Ventures is a Cairo-based deep-tech venture firm deploying $250k-$1M cheques at Seed and Series A into Egyptian and MENA founders building cutting-edge AI and healthcare startups. The firm operates inside a Cairo ecosystem that has produced credible regional AI healthcare exits (Rology, Vezeeta) and benefits from an emerging deep-tech founder pipeline coming out of AUC, Cairo University, and the diaspora. For founders, Sequence is best positioned as a sector-focused early lead for technically ambitious MENA founders building defensible AI healthcare or deep-tech platforms with regional scaling potential. The right founder profile is an Egyptian or MENA operator with strong technical credentials building AI clinical software, diagnostic AI, or health-data platforms with early validation, regulatory awareness, and a credible plan to expand across the Gulf and broader Levant. Founders running consumer wellness, asset-heavy clinic models, or pure commercial plays without technical depth are a poor fit. Entry path is via the Cairo deep-tech founder community, Egypt Ventures and Flat6Labs’ upstream flow, or warm introductions from Gulf-based deep-tech funds (Merak, Wamda, Sanabil). In the pitch, lead with technical defensibility, IP strategy, regulatory positioning through MOHP and Saudi SFDA, Arabic-language localisation, and a credible Series A plan that names likely regional and international leads. Caveats: Egypt’s macro and FX volatility constrain valuation expectations and follow-on capital, so founders should plan Gulf or international leads early. Public deal footprint is still developing for Sequence specifically, so request a recent deal sheet during initial diligence to confirm activity, vintage, and pacing. Confirm reserves and follow-on policy explicitly, and clarify the fund’s appetite for healthcare versus broader deep-tech, since the venture book spans multiple verticals.